Business Description
PharmX Technologies Ltd
NAICS : 511210
ISIN : AU0000298762
Description
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 54.73 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.17 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.76 | |||||
| Beneish M-Score | -2.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -21.8 | |||||
| 3-Year EBITDA Growth Rate | -12.6 | |||||
| 3-Year Book Growth Rate | -10.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.63 | |||||
| 9-Day RSI | 84.19 | |||||
| 14-Day RSI | 81.74 | |||||
| 6-1 Month Momentum % | 32.26 | |||||
| 12-1 Month Momentum % | -4.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.37 | |||||
| Quick Ratio | 1.37 | |||||
| Cash Ratio | 1.1 | |||||
| Days Inventory | 3.85 | |||||
| Days Sales Outstanding | 86.28 | |||||
| Days Payable | 283.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 10.56 | |||||
| Forward Dividend Yield % | 10.56 | |||||
| 5-Year Yield-on-Cost % | 10.56 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 25.85 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.98 | |||||
| Operating Margin % | -21.01 | |||||
| Net Margin % | -27.27 | |||||
| FCF Margin % | 25.02 | |||||
| ROE % | -9.79 | |||||
| ROA % | -5.53 | |||||
| ROIC % | -3.11 | |||||
| ROC (Joel Greenblatt) % | 123.44 | |||||
| ROCE % | 1.22 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| PS Ratio | 6.36 | |||||
| PB Ratio | 2.6 | |||||
| Price-to-Tangible-Book | 7 | |||||
| Price-to-Free-Cash-Flow | 35 | |||||
| Price-to-Operating-Cash-Flow | 14 | |||||
| EV-to-EBIT | 116.39 | |||||
| EV-to-EBITDA | 19.62 | |||||
| EV-to-Revenue | 4.38 | |||||
| EV-to-FCF | 13.07 | |||||
| Price-to-Projected-FCF | 3.5 | |||||
| Price-to-Median-PS-Value | 3.5 | |||||
| Earnings Yield (Greenblatt) % | 0.86 | |||||
| FCF Yield % | 3.93 | |||||
| Forward Rate of Return (Yacktman) % | -14.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PharmX Technologies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 6.487 | ||
| EPS (TTM) (A$) | -0.003 | ||
| Beta | 0.89 | ||
| Volatility % | 65.7 | ||
| 14-Day RSI | 81.74 | ||
| 14-Day ATR (A$) | 0.002949 | ||
| 20-Day SMA (A$) | 0.0555 | ||
| 12-1 Month Momentum % | -4.65 | ||
| 52-Week Range (A$) | 0.012 - 0.08 | ||
| Shares Outstanding (Mil) | 598.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PharmX Technologies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PharmX Technologies Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PharmX Technologies Ltd Frequently Asked Questions
What is PharmX Technologies Ltd(ASX:PHX)'s stock price today?
The current price of ASX:PHX is A$0.07. The 52 week high of ASX:PHX is A$0.08 and 52 week low is A$0.01.
When is next earnings date of PharmX Technologies Ltd(ASX:PHX)?
The next earnings date of PharmX Technologies Ltd(ASX:PHX) is .
Does PharmX Technologies Ltd(ASX:PHX) pay dividends? If so, how much?
The Dividend Yield %  of PharmX Technologies Ltd(ASX:PHX) is 10.56% (As of Today), Highest Dividend Payout Ratio of PharmX Technologies Ltd(ASX:PHX) was 0.63. The lowest was 0.63. And the median was 0.63. The  Forward Dividend Yield % of PharmX Technologies Ltd(ASX:PHX) is 10.56%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers